{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:29:09Z","timestamp":1740130149940,"version":"3.37.3"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"DOI":"10.1093\/jac\/dkab129","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:09:52Z","timestamp":1617736192000},"page":"1950-1951","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study\u2014authors\u2019 response"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-5695","authenticated-orcid":false,"given":"K\u00e9vin","family":"Alexandre","sequence":"first","affiliation":[{"name":"Normandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of Infectious Disease, F 76000 Rouen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Caron","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of Infectious Disease, F 76000 Rouen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"2021070808221887200_dkab129-B1","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkab081","article-title":"Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study","author":"Giske","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2021070808221887200_dkab129-B2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jac\/dkaa486","article-title":"Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study","volume":"76","author":"Alexandre","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2021070808221887200_dkab129-B3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","article-title":"Practice guidelines for the management of adult community-acquired urinary tract infections","volume":"48","author":"Caron","year":"2018","journal-title":"Med Mal Infect"},{"year":"2019","key":"2021070808221887200_dkab129-B4"},{"key":"2021070808221887200_dkab129-B5"},{"key":"2021070808221887200_dkab129-B6","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","article-title":"Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"66","author":"Balakrishnan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2021070808221887200_dkab129-B7","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/jac\/dky101","article-title":"Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods","volume":"73","author":"Alexandre","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021070808221887200_dkab129-B8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2021070808221887200_dkab129-B9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/jac\/dkw066","article-title":"Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli","volume":"71","author":"Alexandre","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2021070808221887200_dkab129-B10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jac\/dky569","article-title":"Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates","volume":"74","author":"Alexandre","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021070808221887200_dkab129-B11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40262-017-0584-7","article-title":"Pharmacokinetics and pharmacodynamics of temocillin","volume":"57","author":"Alexandre","year":"2018","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/7\/1950\/38693551\/dkab129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/7\/1950\/38693551\/dkab129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T16:02:29Z","timestamp":1625760149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/7\/1950\/6248217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4,24]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab129","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,4,24]]}}}